Identification and tissue-specific expression of a NADH-dependent activity of dihydropyrimidine dehydrogenase in man

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 389-394

  Van Kuilenburg, Andre B P ^a,b   Van Lenthe, Henk ^a   Van Gennip, Albert H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

(Potassium phosphate); 5 fluorouracil; Dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase (EC 1.3.1.2); Isoforms; KP(i); PBS (phosphate buffered saline 9.2 mM Na2HPO4, 1.3 mM NaH2PO4 and 140 mM NaCl, pH 7.4 ; Tissue specificity

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SEPHAROSE; THYMINE;

ARTICLE; BINDING AFFINITY; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME PURIFICATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

CELLS, CULTURED; DIHYDROURACIL DEHYDROGENASE (NADP); FIBROBLASTS; HUMANS; KINETICS; LIVER; LYMPHOCYTES; NAD; OXIDOREDUCTASES; SENSITIVITY AND SPECIFICITY; THYMIDINE;

EID: 0029918267     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Heggie GD, Sommadossi J-P, Cross DS, Huster WJ and Diasio RB: Clinical Pharmacokinetics of 5-Fluorouracil and its Metabolism in Plasma, Urine, and Bile. Cancer Res 47; 2203-2206, 1987.
2. Daher GC, Naguib FNM. el Kouni MH, Zhang R, Soong SJ and Diasio, RB: Inhibition of fluoropyrimidine catabolism by benzyloxybenzyluracil. Biochem Pharmacol 41: 1887-1893, 1991.
3. Iigo M, Araki E, Nakajima Y, Hoshi A and De Clercq E: Enhancing effect of bromovinyldeoxyuridine on antitumour activity of 5-fluorouracil against adenocarcinoma 755 in mice. Biochem Pharmacol 37: 1609-1613, 1988.
4. Spector T, Harrington JA and Porter DJT. 5-Ethynyluracl (776C85): inactivation of dihydropyrimidine dehydrogenase in vivo. Biochem Pharmacol 46: 2243-2248, 1993.
5. Diasio RB, Beavers TL and Carpenter JT: Familial Deficiency of Dihydropyrimidine Dehydrogenase, Biochemical Basis for Familial Pyrimidinemia and Severe 5-Fluorouracil-induced Toxicity. J Clin Invest 81: 47-51, 1988.
6. Harris BE, Carpenter JT and Diasio RB. Severe 5-Fluorouracil Toxicity Secondary to Dihydropyrimidine Dehydrogenase Deficiency. Cancer 68: 499-501, 1991.
7. Lyss AP, Lilenbaum RC, Harris BE and Diasio RB: Severe 5-Fluorouracil Toxicity in a Patient with Decreased Dihydropyrimidine Dehydrogenase Activity. Cancer Invest 11: 239-240, 1993.
8. Meinsma R, Fernandez - Salguero P, Van Kuilenburg ABP, Van Gennip AH and Gonzalez FJ: Human Polymorphism in Drug Metabolism: Mutation in the Dihydropyrimidine Dehydrogenase Gene Results in Exon Skipping and Thymine Uraciluria. DNA Cell Biol 14: 1-6, 1995.
9. Shiotani T and Weber G: Purification and Properties of Dihydropyrimidine Dehydrogenase from Rat Liver. J Biol Chem 256: 219-224, 1981.
10. Podschun B, Wahler G and Schnackerz KD: Purification and characterisation of dihydropyrimidine dehydrogenase from pig liver. Eur J Biochem 185: 219-224, 1989.
11. Lu Z-H, Zhang R and Diasio RB: Purification and Characterisation of Dihydropyrimidine dehydrogenase from Human Liver. J Biol Chem 267: 17102-17109, 1992.
12. Lu Z-H, Zhang R and Diasioo RB: Comparison of Dihydropyrimidine dehydrogenase from human, rat, pig and cow liver. Biochem Pharmacol 46: 945-952, 1993.
13. Naguib FNM, el Kouni MH and Cha S: Enzymes of Uracil Catabolism in Normal and Neoplastic Human Tissues. Cancer Res 45: 5405-5412, 1985.
14. Ho DH, Townsend L, Luna MA and Bodey GP: Distribution and Inhibition of Dihydrouracil Dehydrogenase Activities in Human Tissues Using 5-Fluorouracil as a Substrate. Anticancer Res 6: 781-784, 1986.
15. Smith AE and Yamada EW: Dihydrouracil Dehydrogenase of Rat Liver. Separation of Hydrogenases and Dehydrogenase Activities. J Biol Chem 246: 3610-3617, 1971.
16. Hallock RO and Yamada EW: Pyrimidine reducing enzymes of rat liver. Can J Biochem 54. 178-184, 1976.
17. Van Gennip AH, Abeling NGGM, Stroomer AEM, Van Lenthe H and Bakker HD: Clinical and Biochemical Findings in Six Patients with Pyrimidine Degradation Defects. J Inher Metab Dis 17: 130-132, 1994.
18. De Korte D, Haverkort WA, Van Gennip AH and Roos D: Nucleotide Profiles of Normal Blood Cells Determined by High-Performance Liquid Chromatography. Anal Biochem 147: 197-209, 1985.
19. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC: Measurement of Protein Using Bicinchoninic Acid. Anal Biochem 150: 76-85, 1985.
20. Tuchman M, O' Dea RF, Ramnaraine MLR and Mirkin BL. Pyrimidine Base Degradation in Cultured Murine C-1300 Neuroblastoma Cells and in Situ Tumours. J Clin Invest 81: 425-430, 1988.
21. Tuchman M, Roemeling RV, Hrushesky WAM, Sothern RB and O' Dea RF: Dihydropyrimidine Dehydrogenase Activity in Human Blood Mononuclear Cells. Enzyme 42: 15-24, 1989.
22. Cornisch - Bowden A and Eisenthal R: Estimation of michaelis constant and maximum velocity from the direct linear plot. Biochim Biophys Acta 523: 268-272, 1978.
23. Goedde HW, Hoffbauer R and Blume K-G: Reduction of Thymine by Leukocytes. Biochem Genet 2: 93-99, 1968.
24. Porter DJT: Dehalogenating and NADPH-modifying Activities of Dihydropyrimidine Dehydrogenase. J Biol Chem 269: 24177-24182, 1994.
25. Nishino T: The Conversion of Xanthine Dehydrogenase to Xanthine Oxidase and the Role of the Enzyme in Reperfusion Injury. J Biochem 116. 1-6, 1994.
26. Yokota H, Fernandez - Salguero P, Furuya H, Lin K, McBride OW, Podschun B, Schnackerz KD and Gonzalez FJ: cDNA Cloning and Chromosome Mapping of Human Dihydropyrimidine Dehydrogenase, an Enzyme Associated with 5-Fluorouracil Toxicity and Congenital Thymine Uraciluria. J Biol Chem 269: 23192-23196, 1994.
27. Vogels GD and Van der Drift C: Degradation of Purines and Pyrimidines by Micro-organisms. Bacterial Rev 40: 403-468, 1976.
28. West TP: Isolation and characterisation of a dihjydropyrimidine dehydrogenase mutant of Pseudomonas chloroaphis. Arch Microbiol 156: 513-516, 1991.
29. Xu G and West TP: Reductive catabolism of pyrimidine bases by Pseudomonas stutzeri. J Gen Microbiol 138: 2459-2463, 1992.
30. West TP: Pyrimidine ribonucleoside catabolic enzyme activities of Pseudomonas picketti. Antonie van Leeuwenhoek 66: 307-312, 1994.
31. Wasternack C, Lippmann G and Reinbotte H: Pyrimidine-degrading enzymes. Purification and properties of β-ureidopropionase of euglena graciles. Biochim Biophys Acata 570: 341-351, 1979.
32. Kontro P: β-Alanine upatake by mouse brain slices. Neuroscience 8: 153-159, 1983.
33. Zafra F, Aragon MC, Valdivieso F and Gimenez C: β-Alamine transport into plasma membrane vesicles derived from rat brain synaptosomes. Neurochem Res 9: 695-707, 1984.
34. Holopainen I and Kontro P: High-affinity uptake of taurine and β-alanine in primary cultures of rat astrocytes. Neurochem Res 11: 207-215, 1985.